Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Journal of Drugs in Dermatology : JDD|March 17, 2017
Expert Consensus on Cosmetic Outcomes After Treatment of Actinic KeratosisBrian Berman, Glynis R Ablon, Neal D Bhatia, et al.Aesthetic Surgery Journal|May 13, 2015
Treatment of Hyaluronic Acid Filler-Induced Impending Necrosis With Hyaluronidase: Consensus RecommendationsJoel L Cohen, Brian S Biesman, Steven H Dayan, et al.Journal of Drugs in Dermatology : JDD|June 8, 2018
Expert Consensus on Achieving Optimal Outcomes With Absorbable Suspension Suture Technology for Tissue Repositioning and Facial RecontouringZ Paul Lorenc, Glynis Ablon, Julius Few, et al.Aesthetic Surgery Journal|March 22, 2013
A review of onabotulinumtoxinA (Botox)Z Paul Lorenc, Jeffrey M Kenkel, Steven Fagien, et al.Toxins|October 28, 2025
RelabotulinumtoxinA, a Ready-to-Use Formulation Neuromodulator Manufactured with PEARL™ Technology to Maintain High Biological and Specific ActivityUlf Ståhl, Emilia Lekholm, Emil Hamnevik, et al.Aesthetic Surgery Journal|March 22, 2013
A review of AbobotulinumtoxinA (Dysport)Z Paul Lorenc, Jeffrey M Kenkel, Steven Fagien, et al.Aesthetic Surgery Journal|March 22, 2013
IncobotulinumtoxinA (Xeomin): background, mechanism of action, and manufacturingZ Paul Lorenc, Jeffrey M Kenkel, Steven Fagien, et al.Aesthetic Surgery Journal|March 22, 2013
IncobotulinumtoxinA in clinical literatureZ Paul Lorenc, Jeffrey M Kenkel, Steven Fagien, et al.Journal of Drugs in Dermatology : JDD|July 12, 2017
Expert Consensus on Absorbable Advanced Suspension Technology for Facial Tissue Repositioning and Volume EnhancementMark S Nestor, Glynis Ablon, Anneke Andriessen, et al.Aesthetic Surgery Journal|March 22, 2013
Consensus panel's assessment and recommendations on the use of 3 botulinum toxin type A products in facial aestheticsZ Paul Lorenc, Jeffrey M Kenkel, Steven Fagien, et al.Pageof 7